Merck KGaA agrees to acquire Rapid Micro Biosystems for $0.75 a share
RPID•Merck KGaA agreed to acquire all outstanding shares of Rapid Micro Biosystems for $0.75 per share. Closing is expected in December 2026, subject to completion of the tender offer and customary conditions.
1. Acquisition agreement
Merck KGaA agreed to acquire all outstanding shares of Rapid Micro Biosystems for $0.75 per share under a definitive agreement.
2. Expected closing
Closing is expected in December 2026, subject to successful completion of the tender offer, including the minimum tender condition, and customary conditions. The business will join Merck’s Life Science division, expanding its automated microbial quality-control offering for pharmaceutical manufacturing.


